Search

Your search keyword '"Livingstone, Julie"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Livingstone, Julie" Remove constraint Author: "Livingstone, Julie"
98 results on '"Livingstone, Julie"'

Search Results

51. Pan-cancer analysis of whole genomes

54. Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

55. Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy–Resistant Early Breast Cancers

56. Molecular hallmarks of multiparametric MRI visibility in prostate cancer

57. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

58. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

59. Genome-wide germline correlates of the epigenetic landscape of prostate cancer

60. Additional file 1: of Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

61. Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution

62. The molecular hallmarks and clinical consequences of tumor hypoxia in prostate cancer.

63. Widespread and Functional RNA Circularization in Localized Prostate Cancer

64. Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer

65. Abstract 2432: The genomic consequences of tumor hypoxia in human cancers

66. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression

67. A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies

68. Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.

69. Abstract A28: Mutational landscape of TP53 in localized prostate cancer

70. Integrated somatic subtypes of localized intermediate-risk prostate cancer.

71. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

72. Abstract 4339: Prognostic significance of copy number alteration burden in unfavorable intermediate-risk prostate cancers harboring intraductal carcinoma and cribriform architecture

73. Combinatorial genomic and pathological indices for integrated stratification of unfavorable intermediate-risk prostate cancer.

74. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression

75. Copy number alterations of P53, RB1, and MDM2 as prognostic markers in intermediate-risk prostate cancer.

76. Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.

77. Spatial genomic heterogeneity within localized, multifocal prostate cancer

78. Abstract 2966: The mutational landscape of localized gleason 6 and 7 prostate cancer

79. Spatial genomic heterogeneity within localized, multifocal prostate cancer

82. p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition

83. The Prognostic Ease and Difficulty of Invasive Breast Carcinoma

84. CS02-6. Aberrant transcriptional program regulating naive CD4 T-cell activation defines a progressive Multiple Sclerosis subgroup

86. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

87. Additional file 6: Figure S7. of Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

88. Sex differences in oncogenic mutational processes

89. Additional file 6: Figure S7. of Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

90. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

91. Pan-cancer analysis of whole genomes

92. Sex differences in oncogenic mutational processes

93. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

94. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

95. Stringing the Words Together.

96. moPepGen: Rapid and Comprehensive Identification of Non-canonical Peptides.

97. Metapipeline-DNA: A Comprehensive Germline & Somatic Genomics Nextflow Pipeline.

98. The Proteogenomics of Prostate Cancer Radioresistance.

Catalog

Books, media, physical & digital resources